Adel Alhazzani, Fahad S Alajlan, Ali M Alkhathaami, Fahmi Mohammed Al-Senani, Taim A Muayqil, Saeed A Alghamdi, Ammar AlKawi, Saeed AlZahrani, Majid Bakheet, Mohammed Aljohani, Nouran Taher, Abdulkarim Almutairi, Mustafa AlQarni, Sadiq Alsalman, Saeed A Alqahtani, Nouf Almansour, Laila Abukhamsin, Amr Mouminah, Nehal Almodarra, Gamal Mohamed, Meshal Almodhy, Eid Albogumi, Mohamad Alzawahmah, Abdulrahman Alreshaid, Naveed Akhtar, Muhammad Shazam Hussain, Gregory W Albers, Ashfaq Shuaib
BACKGROUND: Following transient ischemic attack (TIA) and minor stroke, the risk of recurrent stroke can be significantly reduced with short-duration dual antiplatelet therapy (DAPT). We wish to investigate whether 10 days of DAPT is as effective as 21 days' treatment. STUDY DESIGN: This is an open-label, randomized, parallel-group study comparing whether 10 days of DAPT treatment (ASA + clopidogrel) is non-inferior to 21 days of DAPT in patients with acute ischemic stroke (AIS) or high-risk TIA...
March 16, 2024: International Journal of Stroke: Official Journal of the International Stroke Society